HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Menopausal hormone therapy and gallbladder disease: the Study of Health in Pomerania (SHIP).

AbstractOBJECTIVE:
Several studies suggest that oral menopausal hormone therapy (MHT) is associated with an increased risk of gallbladder disease. It has been hypothesized that nonoral MHT may reduce the risk of cholelithiasis. The objective of the present study was to analyse the association between (1) use of life-time MHT (ever use) and gallbladder disease and (2) nonoral use of MHT and gallbladder disease.
DESIGN:
Cross-sectional study using population-based data from the Study of Health in Pomerania (SHIP).
POPULATION:
The study population included 994 postmenopausal women, aged 40-79 years. The subgroup of current oral and nonoral MHT users comprised 139 women.
METHODS AND MEASUREMENTS:
Sociodemographic, medical and reproductive characteristics were based on computer-assisted personal interviews, and selected laboratory parameters were analysed. Gallbladder disease was defined by either a prior history of cholecystectomy or the presence of current sonographically diagnosed gallstones. Data analyses consisted of descriptive, bivariable and multivariable procedures. We performed Poisson regression with Huber/White standard errors to investigate the association between ever use, current nonoral use of MHT and gallbladder disease.
RESULTS:
We found no significant association between ever use of MHT and gallbladder disease and sonographically diagnosed gallstones in fully adjusted analyses. Women who used MHT had a significantly higher risk for cholecystectomy compared to nonusers. There was no association between nonoral use of MHT and gallbladder disease.
CONCLUSIONS:
Our analyses do not lend support to the hypothesis that use of MHT is associated with gallbladder disease.
AuthorsS Schwarz, H Völzke, S E Baumeister, J Hampe, M Dören
JournalClinical endocrinology (Clin Endocrinol (Oxf)) Vol. 67 Issue 1 Pg. 51-9 (Jul 2007) ISSN: 0300-0664 [Print] England
PMID17437513 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Cholecystolithiasis (etiology)
  • Cholelithiasis (etiology)
  • Cross-Sectional Studies
  • Estrogen Replacement Therapy (adverse effects)
  • Female
  • Gallbladder Diseases (chemically induced)
  • Gallstones (etiology)
  • Germany
  • Health Surveys
  • Humans
  • Menopause
  • Middle Aged
  • Postmenopause
  • Regression Analysis
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: